sugammadex avansor 100 mg/ml injektioneste, liuos
avansor pharma oy - sugammadex sodium - injektioneste, liuos - 100 mg/ml - sugammadeksi
cabazitaxel mylan 20 mg/ml infuusiokonsentraatti, liuosta varten
mylan ab - cabazitaxel - infuusiokonsentraatti, liuosta varten - 20 mg/ml - kabatsitakseli
cabazitaxel fresenius kabi 20 mg/ml infuusiokonsentraatti, liuosta varten
fresenius kabi ab - cabazitaxel - infuusiokonsentraatti, liuosta varten - 20 mg/ml - kabatsitakseli
tecvayli
janssen-cilag international n.v. - teclistamab - multiple myeloma - antineoplastiset aineet - tecvayli is indicated as monotherapy for the treatment of adult patients with relapsed and refractory multiple myeloma, who have received at least three prior therapies, including an immunomodulatory agent, a proteasome inhibitor, and an anti-cd38 antibody and have demonstrated disease progression on the last therapy.
sugammadex amomed
aop orphan pharmaceuticals gmbh - sugammadex sodium - neuromuskulaarinen estäminen - kaikki muut terapeuttiset tuotteet - neuromuskulaarisen salpauksen aiheuttama rokuronin tai vekuronin. for the paediatric population: sugammadex is only recommended for routine reversal of rocuronium induced blockade in children and adolescents aged 2 to 17 years.
sugammadex qilu 100 mg/ml injektioneste, liuos
qilu pharma spain s.l. - sugammadex sodium - injektioneste, liuos - 100 mg/ml - sugammadeksi
sugammadex stada 100 mg/ml injektioneste, liuos
stada arzneimittel ag - sugammadex sodium - injektioneste, liuos - 100 mg/ml - sugammadeksi
sugammadex orion 100 mg/ml injektioneste, liuos
orion corporation orion pharma - sugammadex sodium - injektioneste, liuos - 100 mg/ml - sugammadeksi
sugammadex gebro 100 mg/ml injektioneste, liuos
gebro pharma gmbh - sugammadex sodium - injektioneste, liuos - 100 mg/ml - sugammadeksi
sugammadex bioglan 100 mg/ml injektioneste, liuos
bioglan ab - sugammadex sodium - injektioneste, liuos - 100 mg/ml - sugammadeksi